logo
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
Nouvelles
À la maison / Nouvelles /

Actualités de l'entreprise The surge in demand for IVD in primary healthcare: new opportunities in the process of transformation

The surge in demand for IVD in primary healthcare: new opportunities in the process of transformation

2025-09-12
The surge in demand for IVD in primary healthcare: new opportunities in the process of transformation

Currently, China's primary healthcare system is undergoing unprecedented transformation and upgrading, leading to explosive growth in the field of in vitro diagnostics (IVD). This trend was confirmed at the recent "Million Talents Gathering in Southern Guangdong" medical and health job fair: 334 employers offered more than 6500 positions, with a particularly prominent demand for professionals in imaging, anesthesia, and other fields in county-level medical institutions. It is worth noting that the development of these departments is closely related to IVD technology, reflecting the strong demand for diagnostic testing in primary healthcare.


The deep driving force behind the surge in demand


The sustained release of policy dividends is the primary driving force. With the support of national policies, the hardware facilities of grassroots medical institutions have been comprehensively upgraded, and modern diagnostic and treatment equipment has been installed in township health centers and village clinics. Hardware improvements have created conditions for carrying out diversified testing projects, while the demand for accurate diagnosis among grassroots doctors has also skyrocketed. The rapid detection technology represented by POCT can precisely meet the dual pursuit of timeliness and accuracy at the grassroots level.


The demographic changes bring new challenges. Global data show that the incidence rate of invasive fungal disease is increasing at an annual rate of 0.9%, and the elderly, especially those with chronic diseases, become vulnerable. The early identification of such diseases at the grassroots level highly relies on IVD technologies such as fungal culture and G-testing, which requires primary healthcare institutions to enhance their diagnostic capabilities.


The deepening implementation of the hierarchical diagnosis and treatment system reshapes the pattern of medical treatment. With the promotion of the policy of first diagnosis at the grassroots level, grassroots medical institutions need to establish a more comprehensive diagnostic system. Fast and reliable IVD testing can not only help doctors timely assess the condition, but also provide scientific basis for patient referrals, effectively improving the efficiency of medical resource utilization.


The deep driving force behind the surge in demand


The sustained release of policy dividends is the primary driving force. With the support of national policies, the hardware facilities of grassroots medical institutions have been comprehensively upgraded, and modern diagnostic and treatment equipment has been installed in township health centers and village clinics. Hardware improvements have created conditions for carrying out diversified testing projects, while the demand for accurate diagnosis among grassroots doctors has also skyrocketed. The rapid detection technology represented by POCT can precisely meet the dual pursuit of timeliness and accuracy at the grassroots level.

The demographic changes bring new challenges. Global data show that the incidence rate of invasive fungal disease is increasing at an annual rate of 0.9%, and the elderly, especially those with chronic diseases, become vulnerable. The early identification of such diseases at the grassroots level highly relies on IVD technologies such as fungal culture and G-testing, which requires primary healthcare institutions to enhance their diagnostic capabilities.


The deepening implementation of the hierarchical diagnosis and treatment system reshapes the pattern of medical treatment. With the promotion of the policy of first diagnosis at the grassroots level, grassroots medical institutions need to establish a more comprehensive diagnostic system. Fast and reliable IVD testing can not only help doctors timely assess the condition, but also provide scientific basis for patient referrals, effectively improving the efficiency of medical resource utilization.


Future Prospects


Despite challenges such as talent shortage and quality control, the grassroots IVD market has enormous potential driven by policy support and technological progress. It is expected that in the coming years, with the integration and application of new technologies such as telemedicine and artificial intelligence, grassroots diagnostic services will develop towards a more intelligent and accurate direction, providing strong support for the construction of a healthy China.


After years of development, Hubei Xindesheng Material Technology will uphold innovative concepts, continuously improve product quality and service levels, and contribute to the development of the IVD industry.